- +1 551 333 1547
- +44 2070 979277
- live:skype_chat
Request Sample Report
View Synopsis & Table of Content
Spinal Muscular Atrophy Comprehensive Study by Type (Type I, Type II, Type III, Type IV), Application (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Others), Treatment (Gene Therapy, Drug {Spinraza, RG6083 (Olesoxime), RG7916}), Administration Route (Oral, Intrathecal) Players and Region - Global Market Outlook to 2027
Spinal Muscular Atrophy Market by Key Segments | Forecast Years: 2022- 2027 | CAGR:12.8%
{reportSlug=global-spinal-muscular-atrophy-market-1, reportId=6029, mktKeyword=Spinal Muscular Atrophy, cagr=12.80, publishDate=Jul 2022, priceOption2=6500, reportTitle=Spinal Muscular Atrophy Comprehensive Study by Type (Type I, Type II, Type III, Type IV), Application (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Others), Treatment (Gene Therapy, Drug {Spinraza, RG6083 (Olesoxime), RG7916}), Administration Route (Oral, Intrathecal) Players and Region - Global Market Outlook to 2027, baseYr=2021, totalTableFig=160, priceOption1=3450, forecastYr=2027, noOfPages=236, reportKey=5965, breadcrum=Global Spinal Muscular Atrophy}
We do not share your information with anyone. However, we may send you
emails based on your report interest from time to time. You may contact
us at any time to opt-out.
Select User Access Type
Key Highlights of Report
Jul 2022
236 Pages
79 Tables
Base Year: 2021
Coverage: 15+ Companies; 18
Countries
